Shopping Cart 0
Cart Subtotal
USD 0

SciClone Pharmaceuticals Inc (SCLN)-Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

SciClone Pharmaceuticals Inc (SCLN)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

SciClone Pharmaceuticals Inc (SciClone) is a pharmaceutical company that develops and commercializes novel therapies for varied therapeutic areas such as oncology, cardiovascular disorders and infectious diseases. The company's lead product, Zadaxin (thymalfasin), an immunostimulatory agent is used for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV), sepsis, cancer and as an immune system enhancer. SciClone also markets other pharmaceutical products in China including DC Bead, a product for the embolization of malignant hypervascularized tumors. Its pipeline products comprise potential therapeutic drugs such as cardiovascular drugs, Angiomax and Neucardin, antibiotic Vibativ and others. The company has presence in Beijing and Shanghai in China; Hong Kong and Vietnam. SciClone is headquartered in Foster City, California, the US.

SciClone Pharmaceuticals Inc Key Recent Developments

Mar 06,2017: SciClone Reports 2016 Financial Results And 2017 Outlook

Nov 09,2016: SciClone Reports Third Quarter 2016 Financial Results

Aug 09,2016: SciClone Reports Second Quarter 2016 Financial Results

Jul 19,2016: SciClone Provides Update On Strategic Review Process

May 10,2016: SciClone Reports First Quarter 2016 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

SciClone Pharmaceuticals Inc-Key Facts 6

SciClone Pharmaceuticals Inc-Key Employees 7

SciClone Pharmaceuticals Inc-Key Employee Biographies 8

SciClone Pharmaceuticals Inc-Major Products and Services 9

SciClone Pharmaceuticals Inc-Pharmaceutical Pipeline Products Data 10

SciClone Pharmaceuticals Inc, Pipeline Products by Therapy Area 10

SciClone Pharmaceuticals Inc, Pipeline Products by Development Phase 11

SciClone Pharmaceuticals Inc-History 12

SciClone Pharmaceuticals Inc-Company Statement 14

SciClone Pharmaceuticals Inc-Locations And Subsidiaries 17

Head Office 17

Other Locations & Subsidiaries 17

Section 2-Company Analysis 18

SciClone Pharmaceuticals Inc-Business Description 18

SciClone Pharmaceuticals Inc-SWOT Analysis 19

SWOT Analysis-Overview 19

SciClone Pharmaceuticals Inc-Strengths 19

SciClone Pharmaceuticals Inc-Weaknesses 20

SciClone Pharmaceuticals Inc-Opportunities 21

SciClone Pharmaceuticals Inc-Threats 22

SciClone Pharmaceuticals Inc-Key Competitors 23

Section 3-Company Financial Ratios 24

Financial Ratios-Capital Market Ratios 24

Financial Ratios-Annual Ratios 25

Performance Chart 28

Financial Performance 28

Financial Ratios-Interim Ratios 29

Financial Ratios-Ratio Charts 30

Section 4-Company's Lifesciences Financial Deals and Alliances 31

SciClone Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 31

SciClone Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 32

SciClone Pharmaceuticals Inc, Recent Deals Summary 33

Section 5-Company's Recent Developments 34

Mar 06, 2017: SciClone Reports 2016 Financial Results And 2017 Outlook 34

Nov 09, 2016: SciClone Reports Third Quarter 2016 Financial Results 36

Aug 09, 2016: SciClone Reports Second Quarter 2016 Financial Results 38

Jul 19, 2016: SciClone Provides Update On Strategic Review Process 40

May 10, 2016: SciClone Reports First Quarter 2016 Financial Results 41

Mar 10, 2016: SciClone Reports 2015 Financial Results 42

Feb 04, 2016: SciClone Announces Final Resolution With The Securities And Exchange Commission And The Department Of Justice 44

Jan 11, 2016: SciClone Announces Preliminary 2015 Revenue 45

Section 6-Appendix 46

Methodology 46

Ratio Definitions 46

About GlobalData 50

Contact Us 50

Disclaimer 50


List Of Figure

List of Figures

SciClone Pharmaceuticals Inc, Pipeline Products by Therapy Area 10

SciClone Pharmaceuticals Inc, Pipeline Products by Development Phase 11

SciClone Pharmaceuticals Inc, Performance Chart (2012-2016) 28

SciClone Pharmaceuticals Inc, Ratio Charts 30

SciClone Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 31

SciClone Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 32


List Of Table

List of Tables

SciClone Pharmaceuticals Inc, Key Facts 6

SciClone Pharmaceuticals Inc, Key Employees 7

SciClone Pharmaceuticals Inc, Key Employee Biographies 8

SciClone Pharmaceuticals Inc, Major Products and Services 9

SciClone Pharmaceuticals Inc, Number of Pipeline Products by Therapy Area 10

SciClone Pharmaceuticals Inc, Number of Pipeline Products by Development Stage 11

SciClone Pharmaceuticals Inc, History 12

SciClone Pharmaceuticals Inc, Subsidiaries 17

SciClone Pharmaceuticals Inc, Key Competitors 23

SciClone Pharmaceuticals Inc, Ratios based on current share price 24

SciClone Pharmaceuticals Inc, Annual Ratios 25

SciClone Pharmaceuticals Inc, Annual Ratios (Cont...1) 26

SciClone Pharmaceuticals Inc, Annual Ratios (Cont...2) 27

SciClone Pharmaceuticals Inc, Interim Ratios 29

SciClone Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 31

SciClone Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 32

SciClone Pharmaceuticals Inc, Recent Deals Summary 33

Currency Codes 46

Capital Market Ratios 46

Equity Ratios 47

Profitability Ratios 47

Cost Ratios 48

Liquidity Ratios 48

Leverage Ratios 49

Efficiency Ratios 49

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

SciClone Pharmaceuticals Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Sarepta Therapeutics Inc Hemispherx Biopharma Inc Enzon Pharmaceuticals Inc Celldex Therapeutics Inc Alnylam Pharmaceuticals Inc